Macquarie Group’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-4,500
| Closed | -$44K | – | 1586 |
|
|
2017
Q1 | $44K | Sell |
4,500
-8,300
| -65% | -$81.2K | ﹤0.01% | 1507 |
|
|
2016
Q4 | $138K | Sell |
12,800
-6,800
| -35% | -$73.3K | ﹤0.01% | 1469 |
|
|
2016
Q3 | $201K | Sell |
19,600
-91,200
| -82% | -$935K | ﹤0.01% | 1407 |
|
|
2016
Q2 | $1.45M | Buy |
110,800
+29,500
| +36% | +$386K | ﹤0.01% | 1213 |
|
|
2016
Q1 | $894K | Buy |
+81,300
| New | +$894K | ﹤0.01% | 1147 |
|